Paul Tudor Jones's KRYS Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 14,476 shares of Krystal Biotech, Inc. (KRYS) worth $3.74 M, representing 0.01% of the portfolio. First purchased in 2021-Q4, this short-term holding has been held for 6 quarters.
Based on 13F filings, Paul Tudor Jones has maintained this position in KRYS for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 13,101 shares. Largest reduction occurred in Q1 2022, reducing 12,562 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Krystal Biotech (KRYS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Krystal Biotech (KRYS) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +13,101 | Add 952.80% | 14,476 | $258.32 |
| Q4 2025 | +1,375 | New Buy | 1,375 | $246.54 |
| Q4 2022 | -11,546 | Sold Out | 0 | $0.00 |
| Q3 2022 | +11,546 | New Buy | 11,546 | $69.72 |
| Q1 2022 | -12,562 | Sold Out | 0 | $0.00 |
| Q4 2021 | +12,562 | New Buy | 12,562 | $69.97 |
Paul Tudor Jones's Krystal Biotech Investment FAQs
Paul Tudor Jones first purchased Krystal Biotech, Inc. (KRYS) in Q4 2021, acquiring 12,562 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Krystal Biotech, Inc. (KRYS) for 6 quarters since Q4 2021.
Paul Tudor Jones's largest addition to Krystal Biotech, Inc. (KRYS) was in Q1 2026, adding 14,476 shares worth $3.74 M.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 14,476 shares of Krystal Biotech, Inc. (KRYS), valued at approximately $3.74 M.
As of the Q1 2026 filing, Krystal Biotech, Inc. (KRYS) represents approximately 0.01% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Krystal Biotech, Inc. (KRYS) was 14,476 shares, as reported at the end of Q1 2026.